Many of our states have been hard hit by drastic
increases in drug overdose deaths in recent years. The number of deaths from heroin overdoses has more than tripled since 2010. Yet according to the Substance Abuse and Mental Health Services Administration, in 2014, less than 12 percent of the 21.5 million
Americans suffering with a substance use disorder received specialty treatment. We would not accept treatment rates this low for other diseases.
Current Medicaid policy, known as the IMD Exclusion, has the unintended consequence of limiting treatment for the most vulnerable populations. Medicaid beneficiaries are prescribed painkillers at twice the rate of non-Medicaid patients, and nearly one-third
of the Medicaid expansion population has a behavioral health disorder—but old Medicaid rules undermine recent coverage gains. This is why we introduced H.R. 2687, the Medicaid Coverage for Addiction Recovery Expansion (CARE) Act.